Our health technology and artificial intelligence practice works at the center of policy discussions in Washington DC. By helping clients track and navigate this exciting and emerging policy area, we are able to ensure our clients are armed with the latest intelligence and involved in relevant conversations and developments impacting health technology products and their regulation.

We work with stakeholders across the health care industry to advance practical and meaningful regulation and legislation.

​Our Services

Health Technology & AI Policy Guidance

We advise clients on the evolving landscape of health technology policy, including the regulation of AI in health care, the use of AI in drug development and clinical trials, software as a medical device, clinical decision support tools, interoperability, health data privacy, and cybersecurity.

Legislative & Regulatory Monitoring

We track and analyze congressional activity, federal agency actions, hearings, proposed rules, guidance documents and enforcement trends affecting health technology and AI. Clients receive timely, practical insights that help them prepare for emerging risks and opportunities.

Policy Strategy and Advocacy

We track and analyze congressional activity, federal agency actions, hearings, proposed rules, guidance documents and enforcement trends affecting health technology and AI. Clients receive timely, practical insights that help them prepare for emerging risks and opportunities.

Federal Affairs Support

We track and analyze congressional activity, federal agency actions, hearings, proposed rules, guidance documents and enforcement trends affecting health technology and AI. Clients receive timely, practical insights that help them prepare for emerging risks and opportunities.

Direct Advocacy

We help clients engage effectively with Congress, federal agencies, and key health policy stakeholders. This includes preparing briefing materials, policy memos, leave-behind documents, as well as comment letters and testimony.